Consenso sobre la detección y el manejo de la prediabetes. Grupo de Trabajo de Consensos y Guías Clínicas de la Sociedad Española de Diabetes

2014, Diagnosis and classification of diabetes, mellitus, Diabetes Care, 37, S81 NICE. Preventing type 2 diabetes: risk identification and interventions for individuals at high risk. NICE public health guidance 38. Issued july 2012 [consultado 20 Ago 2014]. Disponible en: http://www.nice.org.uk/guidance/ph38 Paulweber, 2010, A European evidence based guideline for the prevention of type 2 diabetes, Horm Metab Res, 42, S3, 10.1055/s-0029-1240928 Soriguer, 2012, Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@betesStudy, Diabetologia, 55, 88, 10.1007/s00125-011-2336-9 Pottie, 2012, Canadian Task Force on Preventive Health Care. Recommendations on screening for type 2 diabetes in adults, CMAJ., 184, 1687, 10.1503/cmaj.120732 Simmons, 2011, Effect of population screening for type 2 diabetes on mortality: long-term follow-up of the Ely cohort, Diabetologia., 54, 312, 10.1007/s00125-010-1949-8 Klein Woolthuis, 2013, Vascular outcomes in patients with screen-detected or clinically diagnosed type 2 diabetes: Diabscreen study follow-up, Ann Fam Med., 11, 20, 10.1370/afm.1460 Simmons, 2012, Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial, Lancet., 380, 1741, 10.1016/S0140-6736(12)61422-6 Park, 2008, Screening for type 2 diabetes is feasible, acceptable, but associated with increased short-term anxiety: a randomised controlled trial in British general practice, BMC Public Health., 8, 350, 10.1186/1471-2458-8-350 Eborall, 2007, Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial, BMJ, 335, 486, 10.1136/bmj.39303.723449.55 Franch Nadal, 2010, Evolucion de los indicadores de calidad asistencial al diabético tipo 2 en atencion primaria (1996-2007) Programa de mejora continua de calidad de la Red de Grupos de Estudio de la Diabetes en Atencion Primaria de la Salud, Med Clin (Barc)., 135, 600, 10.1016/j.medcli.2009.06.033 Waugh, 2013, Screening for type 2 diabetes: a short report for the National Screening Committee, Health Technol Assess., 17, 1, 10.3310/hta17350 Noble, 2011, Risk models and scores for type 2 diabetes: systematic review, BMJ., 343, d7163, 10.1136/bmj.d7163 Buijsse, 2011, Risk assessment tools for identifying individuals at risk of developing type 2 diabetes, Epidemiol Rev., 33, 46, 10.1093/epirev/mxq019 Abbasi, 2012, Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study, BMJ., 345, e5900, 10.1136/bmj.e5900 Soriguer, 2012, Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain Pizarra Study, Med Clin (Barc)., 138, 371, 10.1016/j.medcli.2011.05.025 Costa, 2013, Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy, BMC Med., 11, 45, 10.1186/1741-7015-11-45 Costa, 2012, Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention, Diabetologia., 55, 1319, 10.1007/s00125-012-2492-6 Selvin, 2010, Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults, N Engl J Med, 362, 800, 10.1056/NEJMoa0908359 Valdés, 2011, HbA(1c) in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998-2005), Diabetes Metab., 37, 27, 10.1016/j.diabet.2010.07.002 Nathan, 2007, Impaired fasting glucose and impaired glucose tolerance: implications for care, Diabetes Care, 30, 753, 10.2337/dc07-9920 De la Hera, 2013, Real incidence of diabetes mellitus in a coronary disease population, Am J Cardiol., 111, 333, 10.1016/j.amjcard.2012.10.008 The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary. Diab Vasc Dis Res. 2014;11:133-73. World Health Organization (WHO) 2006. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Report of a WHO/IDF [consultado 20 Ago 2014]. Disponible en: http://whqlibdoc.who.int/publications/2006/9241594934_eng.pdf?ua=1 World Health Organization (WHO) 2011. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Systematic review. WHO/NMH/CHP/CPM/111 [Internet]. 2011 [consultado 20 Ago 2014]. Disponible en: http://www.who.int/diabetes/publications/report-hba1c_2011.pdf?ua=1 Forouhi, 2006, The threshold for diagnosing impaired fasting glucose: a position statement by the European Diabetes Epidemiology Group, Diabetologia, 49, 822, 10.1007/s00125-006-0189-4 2014, Standards of Medical Care in Diabetes-2014, Diabetes Care 2014;, 37, S14 James, 2014, Evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the Eighth Joint National Committee (JNC 8), JAMA., 10.1001/jama.2013.284427 Viscogliosi, 2013, Mediterranean dietary pattern adherence: associations with prediabetes, metabolic syndrome, and related microinflammation, Metab Syndr Relat Disord., 11, 210, 10.1089/met.2012.0168 Norris, 2005, Long-term non-pharmacological weight loss interventions for adults with prediabetes, Cochrane Database of Systematic Reviews Umpiérrez, 2014, Primary prevention of type 2 diabetes by lifestyle intervention in primary care setting, Rev Clin Esp, 214, 79, 10.1016/j.rce.2013.11.004 Eriksson, 1991, Prevention of type 2 (non-insulindependent) diabetes mellitus by diet and physical exercise The 6-year Malmo feasibility study, Diabetologia., 34, 891, 10.1007/BF00400196 Pan, 1997, Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance The Da Qing IGT and Diabetes Study, Diabetes Care, 20, 537, 10.2337/diacare.20.4.537 Li, 2008, The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study, Lancet., 371, 1783, 10.1016/S0140-6736(08)60766-7 Tuomilehto, 2001, Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance, N Engl J Med, 344, 1343, 10.1056/NEJM200105033441801 Lindström, 2006, Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study, Lancet., 368, 1673, 10.1016/S0140-6736(06)69701-8 Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512 Knowler, 2009, 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study, Lancet., 374, 1677, 10.1016/S0140-6736(09)61457-4 Kosaka, 2005, Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males, Diabetes Res Clin Pract, 67, 152, 10.1016/j.diabres.2004.06.010 Ramachandran, 2006, The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1), Diabetologia, 49, 289, 10.1007/s00125-005-0097-z Sagarra, 2014, Rev Clin Esp, 214, 59, 10.1016/j.rce.2013.10.005 Estruch, 2013, N Engl J Med, 368, 1279, 10.1056/NEJMoa1200303 Gillett, 2012, Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation, Health Technol Assess., 16, 1, 10.3310/hta16330 Schellenberg, 2013, Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis, Ann Intern Med., 159, 543, 10.7326/0003-4819-159-8-201310150-00007 Dunkley, 2014, Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis, Diabetes Care., 37, 922, 10.2337/dc13-2195 Hamman, 2006, Effect of weight loss with lifestyle intervention on risk of diabetes, Diabetes Care, 29, 2102, 10.2337/dc06-0560 Gong, 2011, Longterm effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study, Diabetologia, 54, 300, 10.1007/s00125-010-1948-9 Li, 2014, Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study, Lancet Diabetes Endocrinol, 2, 474, 10.1016/S2213-8587(14)70057-9 Lacroix, 1998 Haas, 2014, 2012 Standards Revision Task Force National Standars for Diabetes Self-Management Education and Support, Diabetes Care, 37, S144, 10.2337/dc14-S144 2000, American College of Sports Medicine Hordern, 2012, Exercise prescription for patients with type 2 diabetes and pre-diabetes: A position statement from Exercise and Sport Science Australia, J Sci Med Sport, 15, 25, 10.1016/j.jsams.2011.04.005 Gerstein, 2006, Lancet, 368, 1096, 10.1016/S0140-6736(06)69829-2 DeFronzo, 2011, Pioglitazone for diabetes prevention in impaired glucose tolerance, N Engl J Med., 364, 1104, 10.1056/NEJMoa1010949 Zinman, 2010, Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study, Lancet, 376, 103, 10.1016/S0140-6736(10)60746-5 Chiasson, 2002, Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomized trial, Lancet, 359, 2072, 10.1016/S0140-6736(02)08905-5 Gerstein, 2012, ORIGIN Trial Investigators Basal insulin and cardiovascular and other outcomes in dysglycemia, N Engl J Med., 367, 319, 10.1056/NEJMoa1203858 2010, Effect of nateglinide on the incidence of diabetes and cardiovascular events, N Engl J Med, 362, 1463, 10.1056/NEJMoa1001122 Torgerson, 2004, XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients, Diabetes Care, 27, 155, 10.2337/diacare.27.1.155 Phung, 2012, Oral antidiabetic drugs and regression from prediabetes to normoglycemia: a meta-analysis, Ann Pharmacother, 46, 469, 10.1345/aph.1Q554 Rosenbloom, 1999, Emerging epidemic of type 2 diabetes in youth, Diabetes Care, 22, 345, 10.2337/diacare.22.2.345 2000, Type 2 diabetes in children and adolescents, Diabetes Care, 23, 381, 10.2337/diacare.23.3.381 Baranowski, 2006, Presence of diabetes risk factors in a large U.S. eighth-grade cohort, Diabetes Care, 29, 212, 10.2337/diacare.29.02.06.dc05-1037 Wiegand, 2004, Type 2 DM and impaired glucose tolerance in European children and adolescentswith obesity–a problem that is no longer restricted to minority groups, Eur J Endocrinol., 15, 199, 10.1530/eje.0.1510199 López-Capapé, 2006, Frequency of the metabolic syndrome in obese Spanish pediatric population, J Endocrinol, 155, 313 Aguayo, 2013, Absence of diabetes mellitus type 2 in obese children and adolescents in the North of Spain, J Pediatr Endocrinol Metab., 26, 25, 10.1515/jpem-2012-0200 Weiss, 2005, Predictors of changes in glucose tolerance status in obese youth, Diabetes Care, 28, 902, 10.2337/diacare.28.4.902 Carrascosa, 2008 Imperatore, 2012, Projections of type 1 and type 2 diabetes burden in the U.S. population aged 20 years through 2050: dynamic modeling of incidence, mortality, an population growth, Diabetes Care, 35, 2515, 10.2337/dc12-0669